Qiu Hesong: A Visionary Leader, Harnessing AI for Better Healthcare

Most business leaders chase success. Few build legacies.” These words reflect Qiu Hesong’s remarkable journey as a doctor, researcher, and innovator, dedicated to harnessing the power of AI to improve healthcare outcomes and make quality medical care more accessible. As the founder of JIYING TECHNOLOGY, a pioneering medical technology company, Qiu is revolutionizing early gastric and intestinal cancer detection and treatment. With his vast experience and passion for innovation, Qiu is paving the way for a future of medical AI and its potential to transform the lives of millions worldwide, building a legacy in the process.

Qiu’s Journey in Medical Technology

Qiu’s inspirational story is focused on dedication and innovation. He founded JIYING TECHNOLOGY with the ambition to quickly and conveniently treat early gastric cancer and early intestinal cancer and better treat Helicobacter pylori infection so that every cancer patient can be saved at the lowest medical cost. Possessing a solid background in scientific research and project management and a deep understanding of medical artificial intelligence, Qiu is pioneering a new approach to cancer detection as well as treatment.

The Inspiration behind JIYING TECHNOLOGY

Qiu’s journey to founding JIYING TECHNOLOGY was sparked by a profound sense of purpose. As a doctor and a researcher, he witnessed firsthand the devastating impact of a career on patients and their families. The loss of countless lives to this disease ignited a determination in Qiu to create a difference. He envisioned a future where AI could be harnessed to revolutionize cancer detection and treatment, making it more accessible and affordable for all.

With this vision in mind, Qiu set out to establish JIYING TECHNOLOGY, an artificial intelligence medical technology company that integrates artificial intelligence, medicine, life sciences, health, genetics, microbiology, and multiple disciplines. The company’s mission is to develop cutting-edge products that use AI technology to quickly and easily detect and treat early gastric cancer and early intestinal cancer and better manage Helicobacter pylori infection. Qiu’s ultimate goal is to ensure that early cancer patients in the world can get effective treatment at the lowest medical cost, hence saving lives and enhancing the quality of life for patients and their loved ones.

A New Chapter: Sytheon’s Partnership with Hallstar

As Qiu transitioned from an expert to an entrepreneur, he faced numerous challenges. This move required him to expand his skill set beyond professional knowledge to encompass business strategy, management, investment and financing, public relations, and geopolitical crisis awareness. To navigate these hurdles, Qiu adopted a mindset of continuous learning, seeking to broaden his understanding and stay at the leading edge.

Additionally, Qiu recognized the importance of building a strong team. By attracting great talent, he was able to drive innovation and propel his company forward. With a firm heart and course, he has been able to overcome challenges and achieve success as an entrepreneur.

Qiu’s Definition of Success

Core Values at JIYING TECHNOLOGY

The company is guided by a clear philosophy: creating affordable, innovative preventive medicine and protecting global health equity. These core values shape the company’s culture and R&D strategy, driving its objective to value and fair medical R&D.

Balancing Innovation with Commercialization

At JIYING TECHNOLOGY, research and academic work are focused on solving real-world problems. The company recognized that basic research and commercial product development are interdependent, with each informing and improving the other. By combining these elements, JIYING TECHNOLOGY’s products can evolve and improve, ensuring they remain relevant.

Driving Strategic Expansion in Southeast Asia and Africa

Qiu’s decision to expand JIYING TECHNOLOGY into Southeast Asia and Africa was driven by a strategic understanding of the region’s healthcare needs. Given the high prevalence of gastric cancer, intestinal cancer, and Helicobacter pylori infection across the world, and the limited access to medical resources in Southeast Asia and Africa, Qiu recognized an opportunity to make a notable impact.

Keeping the Team Motivated

Qiu keeps his team motivated by emphasizing the impact of their work on protecting lives. By focusing on a shared goal that transcends individual roles, team members are inspired to work together towards a common purpose.

The Key Leadership Lessons

Qiu’s experience navigating local and international regulatory, clinical, and market environments has taught him major leadership lessons. One key takeaway is the importance of respecting the regulatory requirements of each country, which demands continuous learning, adaptability, and strategic planning to achieve their goals.

As a founder, Qiu relies on several key leadership principles when guiding his frontier tech-health company. These include persistence in innovation, respect for technology, meeting the needs of real events, and sharp and fast decision-making.

Fostering Calculated Risk-Taking

Qiu encourages calculated risk-taking and innovation within his leadership team by embracing an adventurous spirit. He finds that failure is an inherent part of innovation and allows for experimentation within certain limits. By summarizing experiences and learning from failures, the team can refine their approach and focus on their goals, driving innovation and growth.

The Pivotal Moment of the Startup Journey

A pivotal moment for Qiu came when advancements in AI development made it more accessible and affordable. The notable breakthroughs in GPU computing power and the emergence of technologies such as CNN and DNN created an environment conducive to innovation. The increasing aging population and rising number of cancer patients highlighted the urgent need for solutions like those Qiu envisions. This blend of technological and demographic trends made him realize it was the best time to launch his tech-health startup, JIYING TECHNOLOGY.

Qiu’s Proudest Moments at JIYING TECHNOLOGY

Since founding JIYING TECHNOLOGY, Qiu has experienced multiple proud moments. One such moment came when clinical data revealed the company’s technology was successfully identifying early cancer patients. Additionally, winning many influential awards in innovative technology competitions validated the company’s approach and impact. The most rewarding opportunity is to deploy JIYING TECHNOLOGY’s solutions in hospitals and communities in need at a very low cost.

The Major Barriers and Opportunities in Medical AI

Qiu identifies two primary barriers to innovation in medical AI, particularly in Asia-Pacific markets: the uneven quality of medical data and the slow or even rejection of innovative products in the medical market. Despite these obstacles, he believes that AI’s potential will pave the way for innovative applications in various AI fields, driving growth and improvement in the industry.

Road Ahead: Qiu’s Long-Term Vision

In the next 5-10 years, Qiu envisions JIYING TECHNOLOGY expanding its reach to more people in Southeast Asia and Africa, driven by technological breakthroughs, such as AI detection of HP-related cancer-related technologies and AI pharmaceutical manufacturing. The company aspires to create a comprehensive technology ecosystem, forming a closed loop of screening, assisted diagnosis, and health management that seamlessly integrates home and hospital care.

Qiu’s long-term vision is for the fusion of AI, genetics, and clinical decision-making to better serve patients and doctors worldwide. He wishes for a future where these are highly integrated, leading to improved healthcare results and a more prosperous future for all stakeholders.